Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Medical Therapy versus Bariatric Surgery in Kidney Transplant Candidates
Bzoma, Beata , Iqbal, Anum , Diwan, Tayyab S. , Kukla, Aleksandra , Bzoma, Beata

Kidney360 | April 14, 2025 | Volume: 6 | Issue: 6 | Pages: 1037-1039

10.34067/kid.0000000813 | PMID 40227854 Get It

Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease
Doskey, Luke C. , Scholtz, Cole R. , Vail, Nora R. , Khanal, Shalil , Lee, Amani L. , Kandanur, Sai Giridhar Sarma , Hoell, Zachariah J. , Huehls, Amelia M. , Issa, Mohamed, Cao, Sheng , Shah, Vijay H. , Issa, Mohamed R , Reid, Joel M , Pomerantz, William C K , Lee, Amani , Kostallari, Enis , Reid, Joel M. , Malhi, Harmeet , Pomerantz, William C. K.

Journal of Medicinal Chemistry | April 14, 2025 | Volume: 68 | Issue: 8 | Pages: 8091-8105

10.1021/acs.jmedchem.4c02555 | PMID 40227166 Get It

CMV Viremia and Colitis in Simultaneous Pancreas-Kidney Transplantation
Singh, Simardeep, Karatela, Shifa , Patel, Mipasha, Amin, Juhi , Gandhi, Devisha, Oring, Justin , Rajani, Aayushi J , Karatela, Shifa , Patel, Mipasha , Amin, Juhi V , Oring, Justin , Rajani, Aayushi J. , Patel, Mipasha, Gandhi, Devisha

American Journal of Case Reports | April 14, 2025 | Volume: 26 | Issue: No issue available | Pages: No page available

10.12659/ajcr.946818 | PMID 40375543 Get It

p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
Rohan, Thomas E. , Zhang, Chenxin , Wang, Yihong , Couch, Fergus J. , Greenlee, Robert T. , Honda, Stacey , Stark, Azadeh , White, Larissa L. , Chitale, Dhananjay , Xue, Xiaonan , Ginsberg, Mindy , Loudig, Olivier , Wang, Yihong , Couch, Fergus J. , Chitale, Dhananjay A , Loudig, Olivier

Cancer Epidemiology, Biomarkers & Prevention | April 14, 2025 | Volume: 34 | Issue: 6 | Pages: 1036-1039

10.1158/1055-9965.epi-25-0143 | PMID 40227115 Get It

Abstract Background: Prior research on the associations of p16, COX-2, and Ki67 immunopositivity in ductal carcinoma in situ (DCIS) tissue with the risk of subsequent ipsilateral invasive breast cancer (IBC) is limited. Methods: In a case–control study nested in a cohort of women diagnosed with DCIS, immunostaining for p16, COX-2, and Ki67 was performed on DCIS tissue from those who developed subsequent ipsilateral IBC (cases; n = 146) and on matched subjects who did not develop IBC (controls; n = 273). Conditional logistic regression was used to estimate ORs and 95% confidence intervals for the associations between immunopositivity for p16, COX-2, and Ki67 and the risk of subsequent ipsilateral IBC. Results: There was no association between p16, COX-2, and Ki67 immunopositivity, examined either individually or in combination, and a risk of ipsilateral IBC. Compared with all other groups, the multivariable OR (95% confidence interval) for women who were triple positive for the three markers was 1.16 (0.38–3.54). Conclusions: p16, COX-2, and Ki67 immunopositivity was not associated with altered risk of ipsilateral IBC in women with DCIS. Impact: p16, COX-2, and Ki67 may not be prognostic for ipsilateral IBC in women with DCIS.
The Risk of Type 2 Diabetes among Older Asian, Native Hawaiian, and Pacific Islander Colorectal Cancer Survivors: A Population-Based Study Using the SEER–Medicare Database
Liu, Kuang‐Yu , Chang, Chun-Pin E. , Lloyd, Shane , Tao, Randa , Nguyen, Timothy , Zhang, Zuo‐Feng , Hashibe, Mia, Liu, Kuangyu , Chang, Chun-Pin Esther , Hashibe, Mia , Lloyd, Shane L , Tao, Randa

Cancer Epidemiology, Biomarkers & Prevention | April 14, 2025 | Volume: 34 | Issue: 6 | Pages: 998-1006

10.1158/1055-9965.epi-25-0037 | PMID 40227116 Get It

Abstract Background: Although colorectal cancer survival rates are improving, the risk of incident type 2 diabetes mellitus (T2D) among Asian, Native Hawaiian, and Pacific Islander (ANHPI) ethnic groups is poorly understood. This study aims to identify high-risk groups and quantify the risk across different periods. Methods: Using the SEER–Medicare database, colorectal cancer survivors who were ANHPI were matched to non-Hispanic White (NHW) survivors at a ratio of 1:3. Multivariable Cox regression models computed HRs and 95% confidence intervals (CI) for incident T2D. Results: The study included 6,463 NHW and 2,901 ANHPI colorectal cancer survivors diagnosed between 2000 and 2017. Among them, 715 NHW and 484 ANHPI developed T2D during 39,097 and 10,769 person-years of follow-up, respectively. ANHPI colorectal cancer survivors had an elevated T2D risk compared with NHW across all follow-up periods (HRoverall: 1.84, 95% CI, 1.51–2.25; HR1–5 years: 1.83, 95% CI, 1.45–2.30). Southeast and East Asians demonstrated the highest T2D risks. Colon cancer was linked to early postdiagnosis T2D risk, whereas rectal cancer was associated with later risk. No significant association was observed for Native Hawaiians and Pacific Islanders. Conclusions: ANHPI colorectal cancer survivors face a greater risk of T2D, particularly among Southeast and East Asians. These findings highlight the need for evidence-based survivorship strategies to prevent T2D and reduce ethnic disparities. Impact: This is the first study to examine T2D risk among ANHPI colorectal cancer survivors, providing critical insights to inform tailored diabetes prevention and survivorship care.
Regulatory T Cell Mimicry by a Subset of Mesenchymal GBM Stem Cells Suppresses CD4 and CD8 Cells
Johnson, Amanda , Korleski, Jack , Sall, Sophie , Li, Yunqing , Zhou, Weiqiang , Smith-Connor, Karen, Laterra, John , López-Bertoni, Hernando , Johnson, Amanda L , Korleski, Jack , Sall, Sophie , Li, Yunqing , Zhou, Weiqiang , Lopez-Bertoni, Hernando , Khela, Harmon Singh

Cells | April 14, 2025 | Volume: 14 | Issue: 8 | Pages: 592

10.3390/cells14080592 | PMID 40277917 Get It

Attempts to activate an anti-tumor immune response in glioblastoma (GBM) have been met with many challenges due to its inherently immunosuppressive tumor microenvironment. The degree and mechanisms by which molecularly and phenotypically diverse tumor-propagating glioma stem cells (GSCs) contribute to this state are poorly defined. In this study, our multifaceted approach combining bioinformatics analyses of clinical and experimental datasets, single-cell sequencing, and the molecular and pharmacologic manipulation of patient-derived cells identified GSCs expressing immunosuppressive effectors mimicking regulatory T cells (Tregs). We showed that this immunosuppressive Treg-like (ITL) GSC state is specific to the mesenchymal GSC subset and is associated with and driven specifically by TGFβ type II receptor (TGFBR2) in contrast to TGFBR1. Transgenic TGFBR2 expression in patient-derived GBM neurospheres promoted a mesenchymal transition and induced a six-gene ITL signature consisting of CD274 (PD-L1), NT5E (CD73), ENTPD1 (CD39), LGALS1 (galectin-1), PDCD1LG2 (PD-L2), and TGFB1. This TGFBR2-driven ITL signature was identified in clinical GBM specimens, patient-derived GSCs, and systemic mesenchymal malignancies. TGFBR2high GSCs inhibited CD4+ and CD8+ T cell viability and their capacity to kill GBM cells, effects reversed by pharmacologic and shRNA-based TGFBR2 inhibition. Collectively, our data identify an immunosuppressive GSC state that is TGFBR2-dependent and susceptible to TGFBR2-targeted therapeutics.
Assessing Morbidity and Mortality in Adult Patients With Acute Traumatic Cervical Spinal Cord Injury Using a Modified Risk Analysis Index
Elsamadicy, Aladine A. , Belkasim, Selma , Sayeed, Sumaiya , Ghanekar, Shaila , Pennington, Zach , Lo, Sheng-Fu Larry , Sciubba, Daniel M. , Pennington, Zach , Serrato, Paul , Hengartner, Astrid C. , Sadeghzadeh, Sina, Khalid, Syed

Neurosurgery | April 14, 2025 | Volume: 97 | Issue: 4 | Pages: 829-841

10.1227/neu.0000000000003443 | PMID 40227044 Get It

BACKGROUND AND OBJECTIVES: The Risk Analysis Index (RAI) is a comprehensive assessment of frailty for predicting neurosurgical outcomes. The aim of this study was to assess whether frailty, measured by a modified RAI (mRAI), was an independent predictor of adverse events (AEs), nonroutine discharge (NRD), and in-hospital mortality for patients with acute cervical spinal cord injuries (SCIs). METHODS: A retrospective cohort study was performed using the American College of Surgeons Trauma Quality Programs database. Adult patients with acute cervical SCI from 2016 to 2022 were stratified by mRAI score into 3 groups: Robust (mRAI 0-10), Frail (mRAI 11-20), and Very Frail (mRAI ≥21). Patient demographics, comorbidities, injury type, diagnostic and treatment modality, AEs, and in-hospital mortality were assessed. A multivariate logistic regression analysis was used to identify independent predictors of AEs, NRD, and in-hospital mortality. RESULTS: 71 048 patients were stratified by mRAI score: 59 796 Robust (84.2%), 9558 Frail (13.5%), and 1694 Very Frail (2.4%). The proportion of SCIs secondary to a fall (Robust: 44.1% vs Frail: 70.2% vs Very Frail: 82.3%; P < .001) and AEs (Robust: 21.5% vs Frail: 24.4% vs Very Frail: 25.0%; P < .001) significantly increased with frailty. Very Frail patients experienced higher NRDs (Robust: 72.3% vs Frail: 85.2% vs Very Frail: 91.0%; P < .001) and in-hospital mortality (Robust: 10.9% vs Frail: 18.3% vs Very Frail: 29.2%; P < .001). On multivariate regression analysis, both Frail (odds ratio [OR]: 1.42; 95% CI: 1.25-1.61; P < .001) and Very Frail (OR: 2.09; 95% CI: 1.46-2.99; P < .001) mRAI scores predicted NRD, but only Frail mRAI score (OR: 1.12; 95% CI: 1.05-1.21; P = .001) was significantly associated with AEs. In addition, Frail (OR: 1.50; 95% CI: 1.36-1.65; P < .001) and Very Frail (OR: 2.79; 95% CI: 2.36-3.29; P < .001) mRAI scores were independent predictors of in-hospital mortality. CONCLUSION: Our study suggests that mRAI may be used to assess morbidity and mortality in patients presenting with spinal cord injury.
Clinical significance of sleepiness: an American Academy of Sleep Medicine position statement
Heffron, Thomas M., Gurubhagavatula, Indira , Trotti, Lynn Marie , Abbasi-Feinberg, Fariha, Abreu, Alexandre Rocha, Bandyopadhyay, Anuja , Kuhlmann, David, Olson, Eric J. , Shelgikar, Anita V., Rowley, James A. , Trotti, Lynn Marie , Kapur, Vishesh K. , Martin, Jennifer L , Patil, Susheel P. , Wickwire, Emerson M.

Journal of Clinical Sleep Medicine | April 14, 2025 | Volume: 21 | Issue: 6 | Pages: 1103-1107

10.5664/jcsm.11658 | PMID 40078104 Get It

Electrode Impedance Subcomponent Analysis in Cochlear Implant Patients with Rising or Fluctuating Electrode Impedances
Saoji, Aniket A. , Graham, Madison K., DeJong, Melissa D., Martin, Joscelyn R. K., Pesch, Joerg, Vanpoucke, Filiep J.

Audiology Research | April 14, 2025 | Volume: 15 | Issue: 2 | Pages: 41

10.3390/audiolres15020041 | PMID 40277586 Get It

Background/Objectives: Electrode impedance is crucial for optimizing cochlear implant (CI) stimulation and hearing outcomes. While typically stable, some patients experience unexplained impedance fluctuations. This study used electrode impedance subcomponent analysis to identify the subcomponents contributing to these impedance fluctuations. Methods: This study analyzed clinical electrode impedances and transimpedance matrix (TIM) measurements in 10 CI patients with Nucleus devices (CI422, CI522, or CI622 electrode arrays) who exhibited fluctuating or rising electrode impedances. TIM measurements used a cathodic-leading biphasic pulse (110 CLs, 75 µs/phase, 7 µs interphase interval). Electrode impedances were determined at 6, 12, 18, 24, and 75 µs, and subcomponents (access resistance [near-field/far-field] and polarization impedance [Warburg capacitance/Faraday resistance]) were calculated. Results: Both access resistance and polarization impedance changes contributed to impedance fluctuations. Large changes in near-field resistance compared to far-field resistance were associated with increased resistance to current flow closer to the surface of the electrode. The decreased double-layer capacitance and slightly increased Faraday resistance further suggested increased resistance to charge transfer at the electrode–electrolyte interface. Conclusions: Electrode impedance subcomponent analysis reveals changes in the electrochemical reaction at the electrode surface that cause fluctuating or rising CI electrode impedances.
Application of kilohertz-frequency block to mitigate off-target motor effects of vagus nerve stimulation in swine
Ludwig, Kip A. , Cheng, Kevin , Gholston, Aaron , LaLuzerne, Maria, Trevathan, James K. , Suminski, Aaron J. , Pelot, Nicole A. , Trevathan, James K , Ludwig, Kip A , Deshmukh, Ashlesha , Settell, Megan L. , Knudsen, Bruce E. , Grill, Warren M. , Ludwig, Kip A.

No container title available | April 14, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6378942/v1 Get It

Abstract Selective activation of smaller diameter over large diameter nerve fibers represents a broad challenge in the electrical modulation of neural activity for clinical applications. For example, off-target activation of motor nerve fibers has been implicated in several failed vagus nerve stimulation (VNS) clinical trials by precluding achieving current amplitudes sufficient to activate the therapeutically targeted small diameter fibers. In this study, we evaluated the use of high-frequency (HF) stimulation to block unwanted activation of large diameter fibers evoked by traditional low-frequency (LF) VNS in a large animal (swine) model. We demonstrate that HF can eliminate specific unwanted LF-evoked components from neural recordings with high selectivity – along with their associated off-target physiological responses - while preserving the activation of smaller diameter fibers driving intended physiological responses. Conversely, block of the smaller diameter fibers was only observed at HF amplitudes much higher than amplitudes commonly used for HF block clinically. We found that in addition to blocking the LF-evoked compound action potential, lower HF amplitudes also drive asynchronous activity which can easily be overlooked. Only at high amplitudes did HF block LF-evoked activation without concomitant asynchronous activation. These data have numerous implications for existing and future LF and HF block neuromodulation therapies.